The disorder is rare, but so severe that the vaccine is on hold while experts weigh the risks and alert doctors and patients about symptoms and treatment.
Many cannot produce enough infection-fighting cells to fend off the coronavirus. But researchers are testing one therapy that may help: monoclonal antibodies.
Despite dire predictions, the number of suicides fell by 5 percent over all. Still, smaller studies suggested the trends were much worse among nonwhite Americans.
An advisory committee debated the very few cases of a rare blood disorder and worried about the suspension’s effect on global needs for a one-shot, easy-to-ship vaccine.
The latest numbers surpass even the yearly tolls during the height of the opioid epidemic and mark a reversal of progress against addiction in recent years.
Out of an “abundance of caution,” the F.D.A. is advising doctors to pause the Johnson & Johnson vaccine while it investigates extremely rare blood clots.
New research found that half of young patients with the inflammatory condition, MIS-C, in a London hospital experienced confusion, hallucinations and other issues, in addition to physical symptoms.
Vaccines do a good job of protecting us from coronavirus, but fear and confusion about the rise of variants have muddled the message. Here are answers to common questions.
The coronavirus may help scientists understand why some people with common viral infections develop severe complications, like heart damage or blood clots.
A Times analysis found that willingness to receive a vaccine and actual vaccination rates to date were both lower, on average, in counties that voted red in the 2020 presidential election.
By Danielle Ivory,?Lauren Leatherby and Robert Gebeloff
